Home
Conditions
Otorhinolaryngologic Diseases

Clinical trial condition

Otorhinolaryngologic Diseases

Explore clinical trials studying Otorhinolaryngologic Diseases. Study availability and eligibility vary by location and protocol.

5,419 public trials 861 recruiting studies

Refine in advanced search Browse all conditions

Otorhinolaryngologic Diseases trial results

Active, Not Recruiting

Dupixent Study for Alternate Administration

NCT06750471

Conditions: Chronic Disease, Disease Attributes, Infections, +11 more
Locations: Madigan Army Medical Center Tacoma, Washington, United States

View Trial Details

Active, Not Recruiting

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT03840421

Conditions: Carcinoma, Head and Neck Neoplasm, Head and Neck Neoplasms, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

NCT06762470

Conditions: Carcinoma, Head and Neck Neoplasms, Histopathological Diagnosis of Nasopharyngeal Carcinoma, +13 more
Locations: Jiangxi Cancer Hospital Nanchang, Jiangxi, China

View Trial Details

Active, Not Recruiting

Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy

NCT06414577

Conditions: Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Diseases, +8 more
Locations: SunYat-senU Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma

NCT05869227

Conditions: Carcinoma, Head and Neck Neoplasms, Maintenance Therapy, +12 more
Locations: SunYat-senU Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Northwestern University Chicago, Illinois, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Active, Not Recruiting

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

NCT02460887

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer

NCT04005521

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +14 more
Locations: Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Active, Not Recruiting

Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC

NCT03813394

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Head and Neck Neoplasms, +15 more
Locations: National University Hospital Singapore

View Trial Details

Active, Not Recruiting

DYsphagiA in interMedIate Care UnitS

NCT04180449

Conditions: Deglutition Disorders, Digestive System Diseases, Dysphagia, +4 more
Locations: Dept of Intensive Care Medicine Bern, Switzerland

View Trial Details

Otorhinolaryngologic Diseases

Otorhinolaryngologic Diseases trial results

Related conditions